ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 676

$432K Total Retail Price of All Prescriptions

Rank: 258 out of 676

497 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 9,850 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 724 653 1 3
SIMVASTATIN 615 490 2 6
OMEPRAZOLE 505 389 3 2
HYDROCHLOROTHIAZIDE 454 342 4 12
BENAZEPRIL HCL 401 352 5 58
METOPROLOL SUCCINATE 313 273 6 14
AMLODIPINE BESYLATE-BENAZEPRIL 270 218 7 44
POTASSIUM CHLORIDE 267 234 8 9
METFORMIN HCL 265 206 9 8
FUROSEMIDE 261 226 10 4
BENAZEPRIL-HYDROCHLOROTHIAZIDE 242 203 11 219
LISINOPRIL 235 197 12 5
CARVEDILOL 232 178 13 15
METOPROLOL TARTRATE 210 182 14 22
HYDROCODONE-ACETAMINOPHEN 204 160 S3 15 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 138 16 16
MELOXICAM 184 144 17 13
ALLOPURINOL 180 128 18 31
LEVOTHYROXINE SODIUM 177 150 19 7
ATORVASTATIN CALCIUM 173 148 20 20
GLYBURIDE-METFORMIN HCL 171 131 R 21 76
RANITIDINE HCL 170 148 22 27
PRAVASTATIN SODIUM 167 130 23 11
GLYBURIDE 158 145 R 24 92
GABAPENTIN 157 134 25 10
WARFARIN SODIUM 152 87 26 18
CRESTOR 147 116 27 29
TRIAMTERENE-HCTZ 144 113 28 43
AMITRIPTYLINE HCL 132 83 R 29 46
DIOVAN HCT 125 109 30 41
SERTRALINE HCL 114 88 31 26
TRAMADOL HCL 99 70 32 19
ATENOLOL-CHLORTHALIDONE 94 85 33 142
LOSARTAN-HYDROCHLOROTHIAZIDE 93 81 34 51
VERAPAMIL ER 91 79 35 101
LOVASTATIN 90 87 36 33
CLONIDINE HCL 86 74 37 32
CITALOPRAM HBR 86 81 37 17
SYNTHROID 83 74 39 48
HYDRALAZINE HCL 83 62 39 77
ATENOLOL 80 61 41 25
FLUTICASONE PROPIONATE 79 68 42 49
CEPHALEXIN 77 60 43 84
ALENDRONATE SODIUM 75 75 44 61
TRAZODONE HCL 67 56 45 36
PREDNISONE 63 43 46 53
BETAMETHASONE VALERATE 57 48 47 304
TAMSULOSIN HCL 56 55 48 38
DIOVAN 56 50 48 37
PAROXETINE HCL 53 24 50 65
ZETIA 53 53 50 89
LOSARTAN POTASSIUM 52 46 52 34
PROAIR HFA 51 33 53 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.